191
Views
23
CrossRef citations to date
0
Altmetric
Review

Targeting nicotine addiction: the possibility of a therapeutic vaccine

, &
Pages 211-224 | Published online: 18 Apr 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Roberto Scendoni, Emanuele Bury, Isabella Lima Arrais Ribeiro, Roberto Cameriere & Mariano Cingolani. (2022) Vaccines as a preventive tool for substance use disorder: A systematic review including a meta-analysis on nicotine vaccines’ immunogenicity. Human Vaccines & Immunotherapeutics 18:6.
Read now
Maciej L. Goniewicz & Marcin Delijewski. (2013) Nicotine vaccines to treat tobacco dependence. Human Vaccines & Immunotherapeutics 9:1, pages 13-25.
Read now

Articles from other publishers (21)

Alejandra Ellison-Barnes & Panagis Galiatsatos. (2022) Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. Medical Clinics of North America 106:6, pages 1067-1080.
Crossref
Benedict T. Bloom & Mary-Jessimine Bushell. (2022) Vaccines against Drug Abuse—Are We There Yet?. Vaccines 10:6, pages 860.
Crossref
Reetakshi Arora, Colin N. Haile, Therese A. Kosten, Yan Wu, Muthu Ramakrishnan, Lynn D. Hawkins, Frank M. Orson & Thomas R. Kosten. (2019) Preclinical efficacy of an anti-methamphetamine vaccine using E6020 adjuvant. The American Journal on Addictions 28:2, pages 119-126.
Crossref
Yicheng Mei & Baowei Yang. (2018) Rational application of drug promiscuity in medicinal chemistry. Future Medicinal Chemistry 10:15, pages 1835-1851.
Crossref
S. Barbosa Méndez & A. Salazar-Juárez. (2018) Current status of nicotine vaccines: A narrative review. Vacunas (English Edition) 19:2, pages 67-78.
Crossref
S. Barbosa Méndez & A. Salazar-Juárez. (2018) Estado actual de las vacunas contra la nicotina: una revisión narrativa. Vacunas 19:2, pages 67-78.
Crossref
A. Micoli, A. De Simone, D. Russo, G. Ottonello, G. Colombano, G. F. RudaT. Bandiera, A. Cavalli & G. Bottegoni. (2016) Aryl and heteroaryl N -[4-[4-(2,3-substituted-phenyl)piperazine-1-yl]alkyl]carbamates with improved physico-chemical properties as dual modulators of dopamine D3 receptor and fatty acid amide hydrolase . MedChemComm 7:3, pages 537-541.
Crossref
Clara Luisa Domínguez-Delgado, Enrique Fuentes-Prado, José Juan Escobar-Chávez, Gustavo Vidal-Romero, Isabel Marlen Rodríguez-Cruz & Roberto Díaz-Torres. 2015. Encyclopedia of Biomedical Polymers and Polymeric Biomaterials. Encyclopedia of Biomedical Polymers and Polymeric Biomaterials 1513 1535 .
Petr O. Ilyinskii & Lloyd P. M. Johnston. 2016. Biologics to Treat Substance Use Disorders. Biologics to Treat Substance Use Disorders 249 278 .
Alimohamad Asghari, Seyed Kamran Kamrava, Mohsen Rezaee Hemami, Maryam Jalessi, Parin Yazdanifard, Mohammad Farhadi, Seyed Behzad Pousti & Seyed Saleh Tabatabaie. (2015) Cigarette Smoking Habit and Subjective Quality of Sleep. Scimetr 3:1.
Crossref
Alessio De Simone, Gian Filippo Ruda, Clara Albani, Glauco Tarozzo, Tiziano Bandiera, Daniele Piomelli, Andrea Cavalli & Giovanni Bottegoni. (2014) Applying a multitarget rational drug design strategy: the first set of modulators with potent and balanced activity toward dopamine D3 receptor and fatty acid amide hydrolase. Chem. Commun. 50:38, pages 4904-4907.
Crossref
Therese B. Bevers, Powel H. Brown, Karen Colbert Maresso & Ernest T. Hawk. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 322 359.e12 .
Lauren Bennett. (2013) Vaccines in trials for nicotine cessation therapy. Journal of the American Academy of Physician Assistants 26:9, pages 55-56.
Crossref
William P. WynnIIIIII, Ron T. Stroman, Michaela M. Almgren & Kelly J. Clark. (2012) The Pharmacist “Toolbox” for Smoking Cessation. Journal of Pharmacy Practice 25:6, pages 591-599.
Crossref
C. D. Gipson & P. W. Kalivas. 2012. Drug Discovery for Psychiatric Disorders. Drug Discovery for Psychiatric Disorders 357 383 .
P. Garrido, A. Prat, I. Crespo, A. Valverde & E. Salvador. (2012) Vacunas para la deshabituación tabáquica. Vacunas 13:4, pages 163-170.
Crossref
Mark G. LeSage, David Shelley, Marco Pravetoni & Paul R. Pentel. (2012) Enhanced attenuation of nicotine discrimination in rats by combining nicotine-specific antibodies with a nicotinic receptor antagonist. Pharmacology Biochemistry and Behavior 102:1, pages 157-162.
Crossref
Harikrishnan Sivadasan Pillai & Sanjay Ganapathi. (2012) Tobacco Cessation Approaches and Impact on CVD. Global Heart 7:2, pages 129.
Crossref
David A Gorelick. (2012) Pharmacokinetic strategies for treatment of drug overdose and addiction. Future Medicinal Chemistry 4:2, pages 227-243.
Crossref
David C.L. Lam & John D. Minna. (2011) How Do We Safely Get People to Stop Smoking?. Cancer Prevention Research 4:11, pages 1724-1727.
Crossref
D. Scot Malay. (2011) Cigarette Smoking and Foot and Ankle Surgery. The Journal of Foot and Ankle Surgery 50:5, pages 515-516.
Crossref